Comprehensive genomic and immunophenotypic analysis of CD4 T cell infiltrating human triple-negative breast cancer
- PMID: 33301062
- PMCID: PMC8139937
- DOI: 10.1007/s00262-020-02807-1
Comprehensive genomic and immunophenotypic analysis of CD4 T cell infiltrating human triple-negative breast cancer
Abstract
The aim of this study is to investigate the gene expression module of tumor-infiltrating CD4+T cells and its potential roles in modulating immune cell functions in triple-negative breast cancer. Differentially expressed genes were identified by comparison of the expression profile in CD4+T cells isolated from tumor tissues and peripheral blood of TNBC patients respectively. The differential expression analysis was conducted using R, and then the functional and pathway enrichment of the DEGs were analyzed using GSEA, followed by integrated regulatory network construction and genetic analysis of tumor-infiltrating immune cells based on a scientific deconvolution algorithm. As a result, abundant Treg and exhausted lymphocytes were detected, accompanied by largely decreased of effector/memory and cytotoxic T cells. Immune-related gene correlation analysis showed that the extent of follicular helper T cells gene expression signatures were inversely associated with those of CD4+ naive T cells and CD4+ memory resting T cells, but positively correlated with that of CD4+ memory activated T cells. In addition, we found five core genes including IFNG, CTLA4, FAS, CXCR6, and JUN were significantly over expressed in CD4+ TILs which may contribute to exhaustion of lymphocytes and participate in biological processes associated with regulation of chemotaxis. Study provides a comprehensive understanding of the roles of DEGs associated with the chemotactic and exhausted immunophenotypes of CD4+ TILs that are a valuable resource from which future investigation may be carried out to better understand the mechanisms that promote TNBC progression.
Keywords: CD4+ T cell; Chemotaxis; Degs; Exhaustion; Gene expression profile; Tils.
Conflict of interest statement
The authors have no conflict of interests.
Figures






Similar articles
-
Composition and plasticity of triple-negative breast carcinoma-infiltrating regulatory T cells.APMIS. 2020 Mar;128(3):260-269. doi: 10.1111/apm.13022. Epub 2020 Jan 28. APMIS. 2020. PMID: 31811667
-
An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers.Breast Cancer Res. 2016 Dec 3;18(1):121. doi: 10.1186/s13058-016-0783-4. Breast Cancer Res. 2016. PMID: 27912781 Free PMC article.
-
The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.Hum Pathol. 2017 Nov;69:110-117. doi: 10.1016/j.humpath.2017.09.012. Epub 2017 Oct 6. Hum Pathol. 2017. PMID: 28993275
-
Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis.BMC Cancer. 2020 Mar 4;20(1):179. doi: 10.1186/s12885-020-6668-z. BMC Cancer. 2020. PMID: 32131780 Free PMC article.
-
Tumor-infiltrating T lymphocytes: friends or foes?Lab Invest. 2006 Mar;86(3):231-45. doi: 10.1038/labinvest.3700389. Lab Invest. 2006. PMID: 16446705 Review.
Cited by
-
Chemokine- and chemokine receptor-based signature predicts immunotherapy response in female colorectal adenocarcinoma patients.Sci Rep. 2023 Dec 4;13(1):21358. doi: 10.1038/s41598-023-48623-2. Sci Rep. 2023. PMID: 38049474 Free PMC article.
-
Guidelines in the management of CNS tumors.J Neurooncol. 2021 Feb;151(3):345-359. doi: 10.1007/s11060-020-03530-8. Epub 2021 Feb 21. J Neurooncol. 2021. PMID: 33611702 Review.
-
Immune microenvironment and prognostic genes of triple-negative breast cancer in the context of transcriptome and single-cell sequencing.Sci Rep. 2025 Aug 13;15(1):29614. doi: 10.1038/s41598-025-15157-8. Sci Rep. 2025. PMID: 40796957 Free PMC article.
-
Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma.Front Genet. 2022 May 18;13:900159. doi: 10.3389/fgene.2022.900159. eCollection 2022. Front Genet. 2022. PMID: 35664309 Free PMC article.
-
Characteristics of recurrence, predictors for relapse and prognosis of rapid relapse triple-negative breast cancer.Front Oncol. 2023 Feb 16;13:1119611. doi: 10.3389/fonc.2023.1119611. eCollection 2023. Front Oncol. 2023. PMID: 36874102 Free PMC article.
References
-
- Harbeck N, Gnant M. Breast cancer. Lancet. 2017;389(10074):1134–1150. - PubMed
-
- Oner G, Altintas S, Canturk Z, Tjalma W, Verhoeven Y, Van Berckelaer C, Berneman Z, Peeters M, Pauwels P, van Dam PA. Triple-negative breast cancer-Role of immunology: a systemic review. Breast J. 2019;26(5):995–999. - PubMed
-
- Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, Drebin JA, Strasberg SM, Eberlein TJ, Goedegebuure PS, Linehan DC. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol. 2002;169(5):2756–2761. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous